Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,035 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Actionable gene alterations in an Asian population with triple-negative breast cancer.
Nagahashi M, Ling Y, Hayashida T, Kitagawa Y, Futamura M, Yoshida K, Kuwayama T, Nakamura S, Toshikawa C, Yamauchi H, Yamauchi T, Kaneko K, Kanbayashi C, Sato N, Miyoshi Y, Tsuchida J, Nakajima M, Shimada Y, Ichikawa H, Lyle S, Takabe K, Okuda S, Wakai T. Nagahashi M, et al. Among authors: miyoshi y. JCO Precis Oncol. 2018;2:PO.17.00211. doi: 10.1200/po.17.00211. Epub 2018 Jul 23. JCO Precis Oncol. 2018. PMID: 32529167 Free PMC article.
No increase of breast cancer incidence in Japanese women who received hormone replacement therapy: overview of a case-control study of breast cancer risk in Japan.
Saeki T, Sano M, Komoike Y, Sonoo H, Honjyo H, Ochiai K, Kobayashi T, Aogi K, Sato N, Sawai S, Miyoshi Y, Takeuchi M, Takashima S. Saeki T, et al. Among authors: miyoshi y. Int J Clin Oncol. 2008 Feb;13(1):8-11. doi: 10.1007/s10147-007-0728-0. Epub 2008 Feb 29. Int J Clin Oncol. 2008. PMID: 18307013
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011.
Kurebayashi J, Miyoshi Y, Ishikawa T, Saji S, Sugie T, Suzuki T, Takahashi S, Nozaki M, Yamashita H, Tokuda Y, Nakamura S. Kurebayashi J, et al. Among authors: miyoshi y. Breast Cancer. 2015 May;22(3):235-44. doi: 10.1007/s12282-015-0599-6. Epub 2015 Mar 11. Breast Cancer. 2015. PMID: 25758809
High absolute lymphocyte counts are associated with longer overall survival in patients with metastatic breast cancer treated with eribulin-but not with treatment of physician's choice-in the EMBRACE study.
Miyoshi Y, Yoshimura Y, Saito K, Muramoto K, Sugawara M, Alexis K, Nomoto K, Nakamura S, Saeki T, Watanabe J, Perez-Garcia JM, Cortes J. Miyoshi Y, et al. Breast Cancer. 2020 Jul;27(4):706-715. doi: 10.1007/s12282-020-01067-2. Epub 2020 Mar 5. Breast Cancer. 2020. PMID: 32133606 Free PMC article. Clinical Trial.
Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple negative breast cancer (TNBC).
Tokumaru Y, Oshi M, Murthy V, Tian W, Yan L, Angarita FA, Nagahashi M, Matsuhashi N, Futamura M, Yoshida K, Miyoshi Y, Takabe K. Tokumaru Y, et al. Among authors: miyoshi y. Am J Cancer Res. 2021 Nov 15;11(11):5743-5755. eCollection 2021. Am J Cancer Res. 2021. PMID: 34873491 Free PMC article.
Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors.
Kanaoka H, Nagahashi M, Atake Y, Hattori A, Bun A, Fukui R, Ozawa H, Fujimoto Y, Higuchi T, Natori K, Imamura M, Murase K, Takatsuka Y, Miyoshi Y. Kanaoka H, et al. Among authors: miyoshi y. Anticancer Res. 2022 Oct;42(10):4867-4878. doi: 10.21873/anticanres.15992. Anticancer Res. 2022. PMID: 36192009
1,035 results